All News
Update on Safety, Effectiveness of SARS-CoV-2 vaccines in SLE
It is almost a year since the Pfizer-BioNTech SARS-CoV-2 vaccine has been made available by the FDA under emergency use authorization (EUA). The question still being asked is whether the vaccine is safe for people with lupus?
Read Article
Improving Rheumatology Practice
How to best book patient appointments in rheumatology clinic? Should these be scheduled every 3 or 4 months regardless of patient status? Should they be scheduled by patient need or disease activity?
Read Article
RheumNow Podcast - Unwillingness to Change Therapy (11.19.21)
Surely you’ve seen this or been plagued by this patient, one that is not doing well, in need of a new regimen; you outline it, timeline it, define the side effects and send them off with a new prescription..
Read Article
MDA in Psoriatic Arthritis: Dr. Rachel Tate ( @uptoTate) discusses abstract #1344 presented at the #ACR21 annual meeting.
https://t.co/E5FNLYQ499 https://t.co/UvdQb3pM36
Links:
Dr. John Cush RheumNow ( View Tweet)
Pulmonary Hypertension in Adult Onset Still's Disease: Dr. Jack Cush reviews poster #1100 presented at the #ACR21 annual meeting.
https://t.co/2YGPHT3AAO https://t.co/lLRKnxB04a
Links:
Dr. John Cush RheumNow ( View Tweet)
COVID-19 Vaccination in Autoimmune Disease: Dr. Sheila Reyes ( @RHEUMarampa) interviews Dr. Latika Gupta about abstract #0444, presented at the #ACR21 annual meeting.
https://t.co/yFqj3fAtrW https://t.co/idWis7FURI
Links:
Dr. John Cush RheumNow ( View Tweet)
Data on Existing SLE Medications, Patient Centered Outcomes, and Exercise: Dr. Michelle Petri discusses data on existing SLE medications, patient-centered outcomes and the importance of exercise, presented Monday at the #ACR21 annual meeting.
https://t.co/iADDiasPZf https://t.co/r84eUtzbcb
Links:
Dr. John Cush RheumNow ( View Tweet)
Long Term Steroid Use in RA - Matters of the Heart: Dr. Mrinalini Dey ( @DrMiniDey) discusses abstract #1428 presented at the #ACR21 annual meeting.
https://t.co/E6RSlPAuRT https://t.co/QBhKD855aH
Links:
Dr. John Cush RheumNow ( View Tweet)
This podcast is devoted to discussing patient satisfaction and factors important in their willingness or unwillingness (resistance) to change therapies.
https://t.co/eVLlD8gEIM https://t.co/B24NWnGLHu
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Type 1 and Type II Lupus — Patient Perspectives: Dr. Mehta ( @bella_mehta) interviews Dr. Clowse about abstract #1277 presented at the #ACR21 annual meeting
https://t.co/2w1Lwwhplf https://t.co/4sJR6DG0q0
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: JAKi Safety: Dr. Aurelie Najm ( @AurelieRheumo) interviews Dr. Choy about JAKi safety data, including abstracts #0958, #1940 and #1941 presented at the #ACR21 annual meeting.
https://t.co/LOM8zz62Pm https://t.co/83HRCZdtfE
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Updates on New Treatments for SpA: Drs. Antoni Chan ( @synovialjoints) interviews Dr. Laura Coates discuss a number of studies related to new treatments for SpA presented at the #ACR21 annual meeting.
https://t.co/aCK1RRvTaW https://t.co/X1TlY88Jng
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Perspectives on CV safety: JAK inhibitor (Tofacitinib) and TNF inhibitors
https://t.co/g5FirIK9Af https://t.co/63s7IaKhl7
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Filgotinib (Jyseleca) was approved by European Commission approved for EU use in adults with moderately to severely active Ulcerative colitis (not responding to conventional therapy or a biologic). Rec based on Phase 2b/3 SELECTION trial. https://t.co/9VbCJse6Tr
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: An Old Friend – Methotrexate in Psoriatic Arthritis
Methotrexate (MTX) remains one of our most used and reliable tools against a variety of rheumatic diseases, particularly in the care of peripheral arthritis such as PsA.
https://t.co/kJdQ9Pd67v
#ACR21 @_Castillo_Pedro https://t.co/lpvZJaPcYd
Links:
Dr. John Cush RheumNow ( View Tweet)
Find all our #ACR21 podcast coverage here.
https://t.co/ZcWxysfoY1 https://t.co/mKOX4suJYi
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Drs. Jack Cush and the RheumNow Faculty Drs. David Liew, Swetha Ann Alexander, Meral El Ramahi, Mrinalini Dey and Robert Chao, discuss highlights from Day 2 at the #ACR21 meeting.
https://t.co/ZaXlhyEKwY
@drdavidliew @swethaann23 @MeralElRamahiMD @DrMiniDey @doctorRBC https://t.co/TNEJUEIRc4
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Emerging Therapies in Psoriatic Arthritis: Drs. Antoni Chan ( @synovialjoints) interviews Dr. FitzGerald about abstract #0490 and other PsA highlights being presented at the #ACR21 annual meeting.
https://t.co/1v8WhMkRHr https://t.co/UbqGkbupUM
Links:
Dr. John Cush RheumNow ( View Tweet)
This podcast is devoted to discussing patient satisfaction and factors important in their willingness or unwillingness (resistance) to change therapies.
https://t.co/QhjXkgW8f2 https://t.co/Zt8BxU0jVf
Links:
Dr. John Cush RheumNow ( View Tweet)
Geriatric Rheumatology:Improving care of aging patients
Dr.Kathryn Dao ( @KDAO2011) moderates a panel w/ Drs.Una Makris, Katherine Wysham, Sebastian Sattui + Devyani Misra, as they discuss aspects of improving care of/outcomes for aging patients. #ACR21
https://t.co/lF3yUZBEkd https://t.co/hYufA8ptqj
Links:
Dr. John Cush RheumNow ( View Tweet)